Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: INM

InMed Pharmaceuticals Inc.

Healthcare | Biotechnology
$1.28
Volume19.7K

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a biotechnology company trading at $1.28. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:47 UTC.

What InMed Pharmaceuticals Inc. does

InMed Pharmaceuticals is a pharmaceutical company developing small molecule drug candidates that target CB1 and CB2 receptors, which are part of the endocannabinoid system found throughout the human body. The company has a pipeline of three programs targeting Alzheimer's disease, dry age-related macular degeneration, and epidermolysis bullosa, with candidates including INM-901, INM-089, and INM-755.

Summarized from InMed Pharmaceuticals Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Quote
Price$1.28
Volume19.7K shares
Valuation
Return on equity-60.76%

Revenue Trend

FY2023: $4M$4MFY2023FY2024: $5M$5MFY2024FY2025: $5M$5MFY2025
Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-08
  • 2026-10-0810% OwnerPurchase5,601$7.4K
  • 2026-10-0810% OwnerPurchase2,256$3.0K
  • 2026-10-0810% OwnerPurchase3,046$4.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does InMed Pharmaceuticals Inc. do?

InMed Pharmaceuticals is a pharmaceutical company developing small molecule drug candidates that target CB1 and CB2 receptors, which are part of the endocannabinoid system found throughout the human body.

What is INM's valuation?

INM trades at $1.28, as of 2026-10-11.

When did INM last file with the SEC?

InMed Pharmaceuticals Inc.'s most recent SEC filing on record is a 8-K filed 2026-09-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:47 UTC. This page is also available as JSON at /api/data?ticker=INM and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for INM and 5,000+ tickers.

Create a free account — keep INM
For your agent
GET /api/data?ticker=INM

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt